Reported Mar 15, 2023 · Terminated
Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis…
Teva Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva Pharmaceuticals USA Inc · 400 Interpace Pkwy Bldg A · Parsippany, NJ · 07054-1120
Is this the product you have?
- Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only
- Manufactured byActavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA
- Distributed byActavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 00591-2720-60
- Lot codes and dates
Lot #: 1410946AExp. 06/2023
- Amount recalled
- 12,044 Bottles
Where it was sold
Why it was recalled
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.